Pasar al contenido principal

METABOLISMO CELULAR Y ELEMENTOS VIRALES CLAVES PARA LA BUSQUEDA DE NUEVOS ANTIVIRALES FRENTE AL VIRUS DEL NILO OCCIDENTAL Y OTROS FLAVIVIRUS RELACIONADOS

PID2019-105117RR-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO NACIONAL DE INVESTIGACIÓN Y TECNOLOGÍA AGRARIA Y ALIMENTARIA - CSIC

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host?

  • Peréz-Pérez, María-Jesús
  • Saiz Calahorra, Juan Carlos
  • Priego, Eva María
  • Martín-Acebes, M. A.
The COVID pandemic has evidenced how vulnerable we are to emerging infectious diseases and how short our current armamentarium is. Flavivirus, single stranded RNA viruses transmitted by arthropods, are considered a global health challenge. No drugs to treat these infections have been approved. In this Viewpoint, we analyze the advantages and disadvantages of two different, but probably also complementary, therapeutic approaches: virus-targeting antivirals and host-targeting drugs, Our own research in the search of antivirals against West Nile virus and other flaviviruses is financed by grants PID2019- 105117RR-C22 and PID2019-105117RR-C21 funded by Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5

  • Albentosa-González, Laura
  • Jiménez de Oya, Nereida
  • Arias, Armando
  • Clemente-Casares, Pilar
  • Martín-Acebes, M. A.
  • Saiz Calahorra, Juan Carlos
  • Sabariegos, Rosario
  • Mas-Barreiro, Antonio
Centro de Biotecnología y Genómica de Plantas (CBGP), Arthropod-borne flaviviruses, such as Zika virus (ZIKV), Usutu virus (USUV), and West Nile virus (WNV), are a growing cause of human illness and death around the world. Presently, no licensed antivirals to control them are available and, therefore, search for broad-spectrum antivirals, including host-directed compounds, is essential. The PI3K/Akt pathway controls essential cellular functions involved in cell metabolism and proliferation. Moreover, Akt has been found to participate in modulating replication in different viruses including the flaviviruses. In this work we studied the interaction of flavivirus NS5 polymerases with the cellular kinase Akt. In vitro NS5 phosphorylation experiments with Akt showed that flavivirus NS5 polymerases are phosphorylated and co-immunoprecipitate by Akt. Polymerase activity assays of Ala- and Glu-generated mutants for the Akt-phosphorylated residues also indicate that Glu mutants of ZIKV and USUV NS5s present a reduced primer-extension activity that was not observed in WNV mutants. Furthermore, treatment with Akt inhibitors (MK-2206, honokiol and ipatasertib) reduced USUV and ZIKV titers in cell culture but, except for honokiol, not WNV. All these findings suggest an important role for Akt in flavivirus replication although with specific differences among viruses and encourage further investigations to examine the PI3K/Akt/mTOR pathway as an antiviral potential target., This research was funded by MINISTERIO DE CIENCIA E INNOVACIÓN, grant numbers SAF2016-80451-P and -PID2019106068GB-I00 to A.M. and A.A.E.; PID2019-105117RR-C21/AEI/ 10.13039/501100011033 to M.Á.M.-A.; P2018/BAA-4370 and E-RTA-2017-00003-C03 to J.-C.S. UNI VERSIDAD DE CASTILLA-LA MANCHA grant numbers GI20163501, GI20174100, and 2019-GRIN 27080 to A.M. A.A. is supported by a Beatriz Galindo Senior Fellowship (BEAGAL18/00074) from MINISTERIO DE UNIVERSIDADES (Spain, Peer reviewed, 17 Págs. This article belongs to the Special Issue Viral Replication Complexes
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara

  • Jiménez de Oya, Nereida
  • Pérez Ramírez, Patricia
  • Blázquez, Ana B.
  • Escribano-Romero, Estela
  • Esteban, Mariano
  • Saiz Calahorra, Juan Carlos
  • García-Arriaza, Juan
  • Martín-Acebes, M. A.
8 Pag.., Zika virus (ZIKV) is a mosquito-borne flavivirus whose infection in pregnant women is associated with a spectrum of birth defects, which are together referred as Congenital Zika Syndrome. In addition, ZIKV can also induce Guillain-Barré syndrome, which is an autoimmune disease with neurological symptoms. The recent description of the first local infections of ZIKV in the European continent together with the expansion of one of its potential vectors, the Asian tiger mosquito (Aedes albopictus), invite us to be prepared for future outbreaks of ZIKV in this geographical region. However, the antigenic similarities of ZIKV with other flaviviruses can lead to an immune cross-reactivity with other circulating flaviviruses inducing, in some cases, flavivirus-disease exacerbation by antibody-dependent enhancement (ADE) of infection, which is a major concern for ZIKV vaccine development. Until now, West Nile virus (WNV) is the main medically relevant flavivirus circulating in the Mediterranean Basin. Therefore, anticipating the potential scenario of emergency vaccination against ZIKV in areas of Europe where WNV is endemic, in this investigation, we have evaluated the cross-reactivity between WNV and our previously developed ZIKV vaccine candidate based on modified vaccinia virus Ankara (MVA) vector expressing ZIKV structural proteins (MVA-ZIKV). To this end, mice were first immunized with MVA-ZIKV, subsequently challenged with WNV, and then, the ZIKV- and WNV-specific immune responses and protection against WNV were evaluated. Our results indicate low cross-reactivity between the MVA-ZIKV vaccine candidate and WNV and absence of ADE, supporting the safety of this ZIKV vaccine candidate in areas where the circulation of WNV is endemic., This research was funded by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación,MCIN/AEI/10.13039/501100011033 grant numbers PID2020-11919JRJ-100 (to N.J.d.O.), PID2019-105117RR-C21 (to M.A.-M.-A.), and E-RTA-2017-00003-C03 (to J.-C.S.); by Comunidad de Madrid, grant number P2018/BAA-4370 PLATESA2-CM (to J.-C.S.); and by Ministerio de Economía y Competitividad grants SAF2013-45232-R and SAF2017-88089-R (AEI/MINECO/FEDER-EU) (to M.E.). P.P. was supported by a Formación de Personal Investigador PhD fellowship from the Spanish Ministry of Health and Education of Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses

  • Pérez Ramírez, Patricia
  • Martín-Acebes, M. A.
  • Poderoso, Teresa
  • Lázaro-Frías, Adrián
  • Saiz Calahorra, Juan Carlos
  • Sorzano, Carlos Óscar S.
  • Esteban, Mariano
  • García-Arriaza, Juan
Centro de Biotecnología y Genómica de Plantas (CBGP), Zika virus (ZIKV) is a mosquito-borne pathogen with public health importance due to the high risk of its mosquito vector dissemination and the severe neurological and teratogenic sequelae associated with infection. Vaccines with broad immune specificity and control against this re-emerging virus are needed. Here, we described that mice immunized with a priming dose of a DNA plasmid mammalian expression vector encoding ZIKV prM-E antigens (DNA-ZIKV) followed by a booster dose of a modified vaccinia virus Ankara (MVA) vector expressing the same prM-E ZIKV antigens (MVA-ZIKV) induced broad, polyfunctional and long-lasting ZIKV-specific CD4+ and CD8+ T-cell immune responses, with high levels of CD4+ T follicular helper cells, together with the induction of neutralizing antibodies. All those immune parameters were significantly stronger in the heterologous DNA-ZIKV/MVA-ZIKV immunization group compared to the homologous prime/boost immunizations regimens. Collectively, these results provided an optimized immunization protocol able to induce high levels of ZIKV-specific T-cell responses, as well as neutralizing antibodies and reinforce the combined use of DNA-based vectors and MVA-ZIKV as promising prophylactic vaccination schedule against ZIKV., This research was supported by MINECO Spanish grants SAF-2013-45232-R and SAF-2017-88089-R (to M.E.) and Grant PID2019-105117RR-C21/AEI/10.13039/501100011033 from Agencia Estatal de Investigación to M.A.M.-A. P.P was supported by a fellowship from the Ministry of Science and Innovation of Spain and this work is part of her Thesis defence., Peer reviewed, 16 Pág.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Relevance of oxidative stress in inhibition of eIF2 alpha phosphorylation and stress granules formation during Usutu virus infection

  • Blázquez, Ana B.
  • Martín-Acebes, M. A.
  • Poderoso, Teresa
  • Saiz Calahorra, Juan Carlos
20 Pág., Usutu virus (USUV) is an African mosquito-borne flavivirus closely related to West Nile, Japanese encephalitis, Zika, and dengue viruses. USUV emerged in 1996 in Europe, where quickly spread across the continent causing a considerable number of bird deaths and varied neurological disorders in humans, including encephalitis, meningoencephalitis, or facial paralysis, thus warning about USUV as a potential health threat. USUV replication takes place on the endoplasmic reticulum (ER) of infected cells, inducing ER stress and resulting in the activation of stress-related cellular pathways collectively known as the integrated stress response (ISR). The alpha subunit of the eukaryotic initiation factor eIF2 (eIF2α), the core factor in this pathway, is phosphorylated by stress activated kinases: protein kinase R (PKR), PKR-like endoplasmic reticulum kinase (PERK), heme-regulated inhibitor kinase (HRI), and general control non-repressed 2 kinase (GCN2). Its phosphorylation results, among others, in the downstream inhibition of translation with accumulation of discrete foci in the cytoplasm termed stress granules (SGs). Our results indicated that USUV infection evades cellular stress response impairing eIF2α phosphorylation and SGs assembly induced by treatment with the HRI activator ArsNa. This protective effect was related with oxidative stress responses in USUV-infected cells. Overall, these results provide new insights into the complex connections between the stress response and flavivirus infection in order to maintain an adequate cellular environment for viral replication., This work was supported by grants RTA2015-009 (J-C. S.) and E-RTA20017-003-C02 (J-C. S.) from INIA, PID2019-105117RR-C21(HOSTMEVIR) (J-C. S.) from the Spanish Ministerio de Ciencia e Innovación, (J-C. S.) from Instituto de Salud Carlos III, and S2018/BAA-4370 (PLATESA-2) (J-C. S.) from the Comunidad Autónoma de Madrid., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation

  • Álvarez-Fernández, Hadrián
  • Mingo-Casas, Patricia
  • Blázquez, Ana B.
  • Caridi, Flavia
  • Saiz Calahorra, Juan Carlos
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
  • Priego, Eva María
Flavivirus comprises globally emerging and re-emerging pathogens such as Zika virus (ZIKV), Dengue virus (DENV), and West Nile virus (WNV), among others. Although some vaccines are available, there is an unmet medical need as no effective antiviral treatment has been approved for flaviviral infections. The development of host-directed antivirals (HDAs) targeting host factors that are essential for viral replication cycle offers the opportunity for the development of broad-spectrum antivirals. In the case of flaviviruses, recent studies have revealed that neutral sphingomyelinase 2, (nSMase2), involved in lipid metabolism, plays a key role in WNV and ZIKV infection. As a proof of concept, we have determined the antiviral activity of the non-competitive nSMase2 inhibitor DPTIP against WNV and ZIKV virus. DPTIP showed potent antiviral activity with EC50 values of 0.26 μM and 1.56 μM for WNV and ZIKV, respectively. In order to unravel the allosteric binding site of DPTIP in nSMase2 and the details of the interaction, computational studies have been carried out. These studies have revealed that DPTIP could block the DK switch in nSMase2. Moreover, the analysis of the residues contributing to the binding identified His463 as a crucial residue. Interestingly, the inhibitory activity of DPTIP on the H463A mutant protein supported our hypothesis. Thus, an allosteric cavity in nSMase2 has been identified that can be exploited for the development of new inhibitors with anti-flaviviral activity., This work was supported by AECSIC, grant number PIE-201980E100 (to M.-J.P.-P.), by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 grants PID2019-105117RR- C21 (to M.A.M-A) and PID2019-105117RR-C22 (to M.-J.P.-P) and by the European Commission—NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Plat- form, PTI+ Salud Global, grants SGL2103053 (to M.A.M.-A.) and SGL2103051 to (M.-J.P.-P.). P.M.-C. was supported by an FPI fellowship (PRE2020-093374) from AEI/10.13039/501100011033. H.Á.-F. was supported by an AEI contract (PEJ2018-002006-A)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Editorial: Lipids in host microbe interaction

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection

  • Jiménez de Oya, Nereida
  • San-Félix, Ana
  • Casasampere, Mireia
  • Blázquez, Ana B.
  • Mingo-Casas, Patricia
  • Escribano-Romero, Estela
  • Calvo Pinilla, Eva María
  • Poderoso, Teresa
  • Casas, Josefina
  • Saiz Calahorra, Juan Carlos
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
The flavivirus life cycle is strictly dependent on cellular lipid metabolism. Polyphenols like gallic acid and its derivatives are promising lead compounds for new therapeutic agents as they can exert multiple pharmacological activities, including the alteration of lipid metabolism. The evaluation of our collection of polyphenols against West Nile virus (WNV), a representative medically relevant flavivirus, led to the identification of N,N'-(dodecane-1,12-diyl)bis(3,4,5-trihydroxybenzamide) and its 2,3,4-trihydroxybenzamide regioisomer as selective antivirals with low cytotoxicity and high antiviral activity (half-maximal effective concentrations [EC50s] of 2.2 and 0.24 μM, respectively, in Vero cells; EC50s of 2.2 and 1.9 μM, respectively, in SH-SY5Y cells). These polyphenols also inhibited the multiplication of other flaviviruses, namely, Usutu, dengue, and Zika viruses, exhibiting lower antiviral or negligible antiviral activity against other RNA viruses. The mechanism underlying their antiviral activity against WNV involved the alteration of sphingolipid metabolism. These compounds inhibited ceramide desaturase (Des1), promoting the accumulation of dihydrosphingomyelin (dhSM), a minor component of cellular sphingolipids with important roles in membrane properties. The addition of exogenous dhSM or Des1 blockage by using the reference inhibitor GT-11 {N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide} confirmed the involvement of this pathway in WNV infection. These results unveil the potential of novel antiviral strategies based on the modulation of the cellular levels of dhSM and Des1 activity for the control of flavivirus infection., We thank Theodore C. Pierson (National Institutes of Health, USA) for the subgenomic replicon of WNV. This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under grants PID2019-105117RR-C21 (to M.A.M.-A.), PID2019-105117RR-C22 (to M.-J.P.-P.), and PID2020-119195RJ-I00 (to N.J.d.O.) and by the AECSIC under grant PIE-201980E100 (to M.-J.P.-P. and A.S.-F.). This research work was also funded by the European Commission-NextGenerationEU (regulation EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global). P.M.-C. was supported by an FPI fellowship (PRE2020-093374) from AEI/10.13039/501100011033. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of West Nile virus RNA-dependent RNA polymerase non-nucleoside inhibitors by real-time high throughput fluorescence screening

  • García-Zarandieta, Marta
  • Quesada, Ernesto
  • Martínez-Jiménez, María I.
  • Newnes, Cristina V
  • Fernández-Cabello, Víctor
  • Saez-Alvarez, Yanira
  • Blázquez, Ana B.
  • Escribano-Romero, Estela
  • Saiz Calahorra, Juan Carlos
  • Del Aguila, Carmen
  • Martín-Acebes, M. A.
  • Peréz-Pérez, María-Jesús
  • Agudo, Ruben
8 pág., West Nile virus (WNV) is a re-emergent mosquito-borne RNA virus that causes major outbreaks of encephalitis around the world. However, there is no therapeutic treatment to struggle against WNV, and the current treatment relies on alleviating symptoms. Therefore, due to the threat virus poses to animal and human health, there is an urgent need to come up with fast strategies to identify and assess effective antiviral compounds. A relevant target when developing drugs against RNA viruses is the viral RNA-dependent RNA polymerase (RdRp), responsible for the replication of the viral genome within a host cell. RdRps are key therapeutic targets based on their specificity for RNA and their essential role in the propagation of the infection. We have developed a fluorescence-based method to measure WNV RdRp activity in a fast and reliable real-time way. Interestingly, rilpivirine has shown in our assay inhibition of the WNV RdRp activity with an IC50 value of 3.3 μM and its antiviral activity was confirmed in cell cultures. Furthermore, this method has been extended to build up a high-throughput screening platform to identify WNV polymerase inhibitors. By screening a small chemical library, novel RdRp inhibitors 1-4 have been identified. When their antiviral activity was tested against WNV in cell culture, 4 exhibited an EC50 value of 2.5 μM and a selective index of 12.3. Thus, rilpivirine shows up as an interesting candidate for repurposing against flavivirus. Moreover, the here reported method allows the rapid identification of new WNV RdRp inhibitors., This work was supported by Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under grant PID2020-115432RB-I00 (to R.A) grant PID2019-105117RR-C21 (to MAM-A); PID2019-105117RR-C22 (to M-JP-P); and from AECSIC under grant PIE-201980E100 (to M-JP-P). This research work was also funded by the European Commission-NextGeneration EU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lipid signatures of West Nile virus infection unveil alterations of sphingolipid metabolism providing novel biomarkers

  • Mingo-Casas, Patricia
  • Sánchez-Céspedes, Javier
  • Blázquez, Ana B.
  • Casas, Josefina
  • Balsera-Manzanero, María
  • Herrero, Laura
  • Vázquez, Ana
  • Pachón, Jerónimo
  • Aguilar-Guisado, Manuela
  • Cisneros, José Miguel
  • Saiz Calahorra, Juan Carlos
  • Martín-Acebes, M. A.
West Nile virus (WNV) is a neurotropic flavivirus transmitted by the bites of infected mosquitoes. Severe forms of West Nile disease (WND) can curse with meningitis, encephalitis or acute flaccid paralysis. A better understanding of the physiopathology associated with disease progression is mandatory to find biomarkers and effective therapies. In this scenario, blood derivatives (plasma and serum) constitute the more commonly used biofluids due to its ease of collection and high value for diagnostic purposes. Therefore, the potential impact of this virus in the circulating lipidome was addressed combining the analysis of samples from experimentally infected mice and naturally WND patients. Our results unveil dynamic alterations in the lipidome that define specific metabolic fingerprints of different infection stages. Concomitant with neuroinvasion in mice, the lipid landscape was dominated by a metabolic reprograming that resulted in significant elevations of circulating sphingolipids (ceramides, dihydroceramides, and dihydrosphingomyelins), phosphatidylethanolamines and triacylglycerols. Remarkably, patients suffering from WND also displayed an elevation of ceramides, dihydroceramides, lactosylceramides, and monoacylglycerols in their sera. The dysregulation of sphingolipid metabolism by WNV may provide new therapeutic opportunities and supports the potential of certain lipids as novel peripheral biomarkers of WND progression., This study was supported by Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under grant PID2019-105117RR-C21 (to MAMA) and by the European Commission – NextGenerationEU through CSIC's Global Health Platform (PTI Salud Global). PMC was supported by a FPI fellowship from AEI/10.13039/501100011033 under grant PRE2020-093374. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dengue Virus Strikes Back: Increased Future Risk of Severe Dengue Disease in Humans as a Result of Previous Exposure to Zika Virus

  • Martín-Acebes, M. A.
  • Saiz Calahorra, Juan Carlos
  • Jiménez de Oya, Nereida
3 Pág., Mosquito-borne flaviviruses include medically important pathogens that are responsible for a variety of human diseases, such as dengue, Zika congenital syndrome, and West Nile fever [...]., This research was funded by The Spanish Ministry of Science and Innovation, grant number PID2019-105117RR-C21 (to M.A.M.-A.), the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, (INIA), grants RTA-2015-00009-00-00 and E-RTA-2017-00003-C02-01, and Comunidad Autónoma de Madrid grant S2018/BAA-4370, PLATESA2-CM (to J.-C.S.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Susceptibility and transmissibility of SARS-CoV-2 variants in transgenic mice expressing the cat angiotensin-converting enzyme 2 (ACE-2) receptor

  • Jiménez de Oya, Nereida
  • Calvo Pinilla, Eva María
  • Mingo-Casas, Patricia
  • Escribano-Romero, Estela
  • Blázquez, Ana B.
  • Esteban, Ana
  • Fernández González, Raúl
  • Pericuesta Camacho, Eva
  • Sánchez-Cordón, Pedro J.
  • Martín-Acebes, M. A.
  • Gutiérrez-Adán, Alfonso
  • Saiz Calahorra, Juan Carlos
9 Pág., The emergence of SARS-CoV-2 in 2019 and its rapid spread throughout the world has caused the largest pandemic of our modern era. The zoonotic origin of this pathogen highlights the importance of the One Health concept and the need for a coordinated response to this kind of threats. Since its emergence, the virus has caused >7 million deaths worldwide. However, the animal source for human outbreaks remains unknown. The ability of the virus to jump between hosts is facilitated by the presence of the virus receptor, the highly conserved angiotensin-converting enzyme 2 (ACE2), found in various mammals. Positivity for SARS-CoV-2 has been reported in various species, including domestic animals and livestock, but their potential role in bridging viral transmission to humans is still unknown. Additionally, the virus has evolved over the pandemic, resulting in variants with different impacts on human health. Therefore, suitable animal models are crucial to evaluate the susceptibility of different mammalian species to this pathogen and the adaptability of different variants. In this work, we established a transgenic mouse model that expresses the feline ACE2 protein receptor (cACE2) under the human cytokeratin 18 (K18) gene promoter's control, enabling high expression in epithelial cells, which the virus targets. Using this model, we assessed the susceptibility, pathogenicity, and transmission of SARS-CoV-2 variants. Our results show that the sole expression of the cACE2 receptor in these mice makes them susceptible to SARS-CoV-2 variants from the initial pandemic wave but does not enhance susceptibility to omicron variants. Furthermore, we demonstrated efficient contact transmission of SARS-CoV-2 between transgenic mice that express either the feline or the human ACE2 receptor., This study was supported by Fundación BBVA, FBBVA-Eco-Vet-Covid-19 (to AGA), by the Spanish Ministry of Science and Innovation AEI under grants PID2020-119195RJ-I00 (to NJO) and PID2019-105117RR-C21 (to MAMA), by CSIC under grant 202340E181 (to MAMA) and by the European Commission – NextGenerationEU through CSIC's Global Health Platform, PTI Salud Global SGL2103053 (to MAMA). PMC was supported by an FPI fellowship from AEI / 10.13039/501100011033 under grant PRE2020-093374. The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals

  • Álvarez-Mínguez, Alejandra
  • Río, Natalia del
  • Blázquez, Ana-Belén
  • Casanova, Elena
  • Orduña, José-María
  • Camarero, Patricia
  • Hurtado-Marcos, Carolina
  • Águila, Carmen del
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
  • Agudo, Rubén
West Nile virus (WNV) is a flavivirus responsible for causing febrile illness and severe neurological diseases, with an increasing impact on human health around the world. However, there is still no adequate therapeutic treatment available to struggle WNV infections. Therefore, there is an urgent need to develop new techniques to accelerate the discovery of drugs against this pathogen. The main protein implicated in the replication of WNV is the non-structural protein 5 (NS5). This multifunctional protein contains methyltransferase (MTase) activity involved in the capping formation at the 5′-end of RNA and the methylation of internal viral RNA residues, both functions being essential for viral processes, such as RNA translation and escape from the innate immune response. We have developed a straightforward luminescence-based assay to monitor the MTase activity of the WNV NS5 protein with potential for high-throughput screening. We have validated this method as a sensitive and suitable assay for the identification of WNV MTase inhibitors assessing the inhibitory effect of the broad MTase inhibitor sinefungin, a natural nucleoside analog of the universal methyl donor S-adenosyl methionine (SAM). The screening of a small series of purine derivatives identified an adenosine derivative as a dose-dependent inhibitor of the MTase activity. The antiviral efficacy of this compound was further confirmed in WNV infections, displaying a measurable antiviral effect. This result supports the utility of this novel method for the screening of inhibitors against WNV MTase activity, which can be of special relevance to the discovery and development of therapeutics against WNV., This work was supported by Ministerio de Ciencia e Innovación y Universidades, Agencia Estatal de Investigación MICIU/AEI/10.13039/ 501,100,011,033 under grants PID2020–115432RB-I00 (to RA), PID2019–105117RR-C21 (to MAM-A), PID2019–105117RR-C22 (to MJP-P), PID2022–137372OR-C21 (to MAM-A) and PID2022–137372ORC21 (to M-JP-P), by the European Commission—Next Generation EU through CSIC’s Global Health Platform (PTI Salud Global) (to M-JP-P and MAM-A) and by CSIC-PIE202380E090 (to M-JP-P). AA-M. is the recipient of an FPU-predoctoral fellowship FPU22/03025 granted by MICIU/AEI/10.13039/501,100,011,033 and the FSE+. The funders did not participate in the study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reprogramming of liver metabolism during West Nile virus infection unveils novel aspects of disease pathophysiology

  • Mingo-Casas, Patricia
  • Blázquez, Ana-Belén
  • Casas, Josefina
  • Esteban, Ana
  • Escribano-Romero, Estela
  • Sánchez-Cordón, Pedro J.
  • Jiménez de Oya, Nereida
  • Saiz, Juan-Carlos
  • Martín-Acebes, M. A.
[Data availability] The RNA-seq datasets generated during the current study have been deposited in the Gene Expression Omnibus with the primary accesion code GSE242981., [Background] West Nile virus (WNV) is a neurotropic mosquito-borne flavivirus responsible for outbreaks of encephalitis and meningitis worldwide. About 20% of infected patients exhibit abnormal liver function tests, although the participation of this organ in the pathophysiology of the disease remains unclear. To fill this gap, this study explores changes in liver metabolism during WNV infection., [Methods] Given the relevance of the liver as a major immune and metabolic organ, the changes in response to WNV infection were analyzed in the mouse model combining transcriptomics, lipidomics and histopathological analyses., [Results] Despite the absence of detectable viral replication in the liver, infection resulted in hepatic transcriptomic reprogramming that affected inflammation, immunity, biological oxidation and lipid metabolisms. Changes in the expression of genes related to glutathione metabolism, detoxification reactions, fatty acid metabolism (fatty acid oxidation and fatty acyl-CoA biosynthesis), phospholipid synthesis (phosphatidylcholine and phosphatidylethanolamine), sphingolipid synthesis, sterol metabolism and lipid droplet organization were identified. The reduction in glutathione in the liver of infected animals was confirmed and lipidomic analyses showed an increase in the content of sphingolipids, triacylglycerols and cholesteryl esters. A decrease in the cholesterol, phosphatidylcholine and phosphatidylethanolamine levels was also observed. Moreover, histopathological findings supported the development of steatosis in one-third of WNV-infected animals., [Conclusions] The discovery of these underestimated metabolic aspects of the infection repurposes the impact of WNV on liver function. These results will contribute to a better understanding of the physiopathology of the disease and warrant special attention to liver function during WNV infection., This study was supported by Spanish Ministry of Science and Innovation AEI/https://doi.org/10.13039/501100011033 and FEDER, EU under grants PID2019-105117RR-C21 (to MAMA), PID2022-137372OR-C21 (to MAMA), PID2020-119195RJ-I00 (to NJO), Community of Madrid under grant TEC-2024/BIO-66/SALAINDEC-CM (to MAMA) and by the European Commission– NextGenerationEU through CSIC's Global Health Platform (PTI Salud Global). PMC was supported by a FPI fellowship from AEI/https://doi.org/10.13039/501100011033 under grant PRE2020-093374. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus

  • Mingo-Casas, Patricia
  • Álvarez-Fernández, Hadrián
  • Blázquez, Ana-Belén
  • Esteban, Ana
  • Escribano-Romero, Estela
  • Jiménez de Oya, Nereida
  • Calvo-Pinilla, Eva
  • Peréz-Pérez, María-Jesús
  • Priego, Eva María
  • Martín-Acebes, Miguel A
West Nile virus (WNV) is a neurotropic flavivirus transmitted by the bites of infected mosquitoes. Severe forms of the disease include meningitis, encephalitis, acute flaccid paralysis, or even death, and survivors develop long-lasting sequelae. The damage induced by WNV does not only stem from viral multiplication but also arises from immune-related pathology linked to neuroinflammation. Certain sphingolipids are key players in WNV infection, neurodegenerative diseases and inflammatory disorders. Neutral sphingomyelinase 2 (nSMase2), catalyzes the conversion of sphingomyelin into ceramide and is essential for flavivirus multiplication. Thus, nSMase2 constitutes a promising therapeutic target for the development of dual-acting antiviral and anti-inflammatory therapies against WNV. The effect of an orally bioavailable and brain-penetrating prodrug of the potent nSMase2 inhibitor DPTIP (DPTIP-P1) was studied in WNV-infected mice. While no reduction in the viral load in the brain of infected animals was observed, WNV-induced expression of inflammatory markers was modulated, resulting in a reduced IL-1β expression in brain. Transcriptomic analyses revealed that treatment with the DPTIP prodrug also modulated the expression of various genes related to immune cell function without altering antiviral innate response. Among others, DPTIP-P1 reduced the expression of Lyz2, an inducible genetic marker associated with macrophage infiltration, and modified the expression of genes related to T cell activation such as Trbc1 and Ptnp22. These results identify nSMase2 inhibitors as a new type of immune modulators of WNV infection. The neuroprotective effects exerted by DPTIP-P1 could contribute to mitigate WNV-induced neuroinflammation and sequelae., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants PID2019- 105117RR-C21 (to MAMA), PID2019-105117RR-C22 (to MJPP) and PID2020-119195RJ-I00 (to NJO); Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 and FEDER, EU under grants PID2022-137372OR-C21 (to MAMA), PID2022-137372OR-C22 (MJPP and EMP), by Comunidad de Madrid under grant TEC-2024/BIO-66/ SALAINDEC-CM (to MAMA) and by the European Commission—NextGenerationEU through CSIC’s Global Health Platform (PTI Salud Global). PMC was supported by an FPI fellowship from AEI/ 10.13039/501100011033 under Grant PRE2020-093374. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed